| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/17/2022 | Decibel Therapeutics, Inc. | DBTX | Grant | Stock Option (right to buy) | 10k | $2.30 | $23k | | 06/17/2022 |
| 06/16/2022 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 15k | $6.80 | $102k | | 06/16/2022 |
| 06/16/2022 | Revolution Medicines, Inc. | RVMD | Grant | Common Stock | 5.2k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | Revolution Medicines, Inc. | RVMD | Grant | Stock Option (Right to Buy) | 18.4k | $16.80 | $309.1k | | 06/16/2022 |
| 06/29/2021 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 13.3k | $28.20 | $374.7k | | 06/29/2021 |
| 06/22/2021 | Revolution Medicines, Inc. | RVMD | Grant | Common Stock | 3.6k | $0.00 | $0 | | 06/22/2021 |
| 06/22/2021 | Revolution Medicines, Inc. | RVMD | Grant | Stock Option (Right to Buy) | 12.7k | $32.93 | $416.9k | | 06/22/2021 |
| 02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Series A Preferred Stock | 45.6M | $0.00 | $0 | See footnote | 02/17/2021 |
| 02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Series C Preferred Stock | 1.2M | $0.00 | $0 | See footnote | 02/17/2021 |
| 02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Series D Preferred Stock | 289.6k | $0.00 | $0 | See footnote | 02/17/2021 |
| 02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Common Stock | 2.9M | $0.00 | $0 | See footnote | 02/17/2021 |
| 02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Common Stock | 98.9k | $0.00 | $0 | See footnote | 02/17/2021 |
| 02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Common Stock | 54.6k | $0.00 | $0 | See footnote | 02/17/2021 |
| 02/11/2021 | Decibel Therapeutics, Inc. | DBTX | Grant | Stock Option(right to buy) | 20k | $18.00 | $360k | | 02/11/2021 |
| 06/05/2020 | PLIANT THERAPEUTICS, INC. | PLRX | Conversion | Series A Preferred Stock | 0 | $0.00 | $0 | See Footnote | 06/05/2020 |
| 03/31/2020 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 26.6k | $0.00 | $0 | | 06/05/2020 |
| 02/18/2020 | Revolution Medicines, Inc. | RVMD | Conversion | Series C Convertible Preferred Stock | 0 | $0.00 | $0 | See Footnote | 02/18/2020 |
| 02/12/2020 | Revolution Medicines, Inc. | RVMD | Grant | Stock Option (Right to Buy) | 36.2k | $17.00 | $614.9k | | 02/12/2020 |
| 06/06/2018 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Grant | Stock Option (right to buy) | 10k | $34.89 | $348.9k | | 06/06/2018 |
| 10/10/2017 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Conversion | Series A Convertible Preferred Stock | 0 | $0.00 | $0 | See Footnotes | 10/10/2017 |
| 10/10/2017 | RHYTHM PHARMACEUTICALS, INC. | RYTM | Conversion | Series A-1 Junior Preferred Stock | 0 | $0.00 | $0 | See Footnotes | 10/10/2017 |
| 06/10/2016 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (right to buy) | 14k | $10.17 | $142.4k | | 06/10/2016 |